• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.35% Nasdaq Up 0.35%

    Geron Corporation (GERN)

    -NasdaqGS
    3.84 Up 0.04(0.92%) 12:40PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.80
    Open:3.84
    Bid:3.83 x 3100
    Ask:3.84 x 500
    1y Target Est:5.50
    Beta:1.92
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:3.79 - 3.88
    52wk Range:1.76 - 4.49
    Volume:417,635
    Avg Vol (3m):3,873,340
    Market Cap:606.27M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNUp 0.92%606.27M
    BMYUp 0.24%109.95B
    GSKDown 0.38%106.43B
    NVSUp 0.81%251.16B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):494.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.07
    Quarterly EPS Est (Jun-15) :-0.06
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-10.96

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback